Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutrients ; 14(5)2022 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-35267998

RESUMEN

The steroidal alkaloid tomatidine is an aglycone of α-tomatine, which is abundant in tomato leaves and has several biological activities. Tomatidine has been reported to inhibit the growth of cultured cancer cells in vitro, but its anti-cancer activity in vivo and inhibitory effect against gastric cancer cells remain unknown. We investigated the efficacy of tomatidine using human gastric cancer-derived 85As2 cells and its tumor-bearing mouse model and evaluated the effect of tomatidine-rich tomato leaf extract (TRTLE) obtained from tomato leaves. In the tumor-bearing mouse model, tumor growth was significantly inhibited by feeding a diet containing tomatidine and TRTLE for 3 weeks. Tomatidine and TRTLE also inhibited the proliferation of cultured 85As2 cells. Microarray data of gene expression analysis in mouse tumors revealed that the expression levels of mRNAs belonging to the type I interferon signaling pathway were altered in the mice fed the diet containing tomatidine and TRTLE. Moreover, the knockdown of one of the type I interferon-stimulated genes (ISGs), interferon α-inducible protein 27 (IFI27), inhibited the proliferation of cultured 85As2 cells. This study demonstrates that tomatidine and TRTLE inhibit the tumor growth in vivo and the proliferation of human gastric cancer-derived 85As2 cells in vitro, which could be due to the downregulation of ISG expression.


Asunto(s)
Alcaloides , Solanum lycopersicum , Neoplasias Gástricas , Alcaloides/metabolismo , Alcaloides/farmacología , Animales , Humanos , Interferones , Ratones , Extractos Vegetales/farmacología , Neoplasias Gástricas/tratamiento farmacológico , Neoplasias Gástricas/genética , Tomatina/análogos & derivados
2.
Nutrients ; 12(10)2020 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-33086536

RESUMEN

Skeletal muscle, the largest organ in the human body, accounting for approximately 40% of body weight, plays important roles in exercise and energy expenditure. In the elderly, there is often a progressive decline in skeletal muscle mass and function, a condition known as sarcopenia, which can lead to bedridden conditions, wheelchair confinement as well as reducing the quality of life (QOL). In developed countries with aging populations, the prevention and management of sarcopenia are important for the improvement of health and life expectancy in these populations. Recently, vitamin D, a fat-soluble vitamin, has been attracting attention due to its importance in sarcopenia. This review will focus on the effects of vitamin D deficiency and supplementation on sarcopenia.


Asunto(s)
Suplementos Dietéticos , Fenómenos Fisiológicos Nutricionales del Anciano/fisiología , Sarcopenia/prevención & control , Sarcopenia/terapia , Vitamina D/administración & dosificación , Atrofia/genética , Femenino , Proteína Forkhead Box O1/genética , Proteína Forkhead Box O1/metabolismo , Expresión Génica/efectos de los fármacos , Humanos , Hipertrofia/genética , Masculino , Proteínas Musculares/metabolismo , Fuerza Muscular , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Prevalencia , Calidad de Vida , Ingesta Diaria Recomendada , Sarcopenia/etiología , Sarcopenia/metabolismo , Serina-Treonina Quinasas TOR/metabolismo , Vitamina D/metabolismo , Vitamina D/farmacología , Vitamina D/fisiología , Deficiencia de Vitamina D
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA